Sign in
4

Changes in Ownership

Lycia Therapeutics, Inc. Filed Acc 0001750495-26-000007

Options or other derivatives

  • President and CEO acquired 443,586 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Trombley Aetna Wun President and CEO 2026-08-11 Grant or award · Stock Option (Right to Buy) +443,586 443,586 D
Loading xslF345X06/form4-10262026_101023.xml…